Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001073640 | SCV001239191 | uncertain significance | Retinal dystrophy | 2019-07-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000085371 | SCV001540161 | likely pathogenic | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine, which is basic and polar, with threonine, which is neutral and polar, at codon 346 of the ABCA4 protein (p.Lys346Thr). This variant is present in population databases (rs61752389, gnomAD 0.0009%). This missense change has been observed in individual(s) with clinical features of ABCA4-related conditions (PMID: 23953153, 26230768, 26551331, 35120629). ClinVar contains an entry for this variant (Variation ID: 99028). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Retina International | RCV000085371 | SCV000117508 | not provided | not provided | no assertion provided | not provided |